Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 23, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

Development and Validation of a Machine Learning-Based Individualized Model to Predict TKI Benefit in Postoperative

Meng Li1,2, Yumin Jiang1, Lin Gong2

  • 1Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Qingdao University, Qingdao, Shandong, People's Republic of China.

Journal of Hepatocellular Carcinoma
|June 22, 2026
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Role of Therapeutic Apheresis in the Management of Rheumatoid Arthritis A Systematic Review and Meta-Analysis.

Journal of clinical apheresis·2026
Same author

Haemolytic disease of the foetus and newborn due to anti-M: A systematic review.

Vox sanguinis·2026
Same author

Jasmonic acid and PpeMYC2 regulate peach fruit ripening by controlling polyamine levels and anthocyanin biosynthesis.

Plant physiology·2026
Same author

Enhancing Second Language Acquisition: The Role of Code-Switching in Mobile English Language Learning.

Journal of psycholinguistic research·2026
Same author

Supratopological Ion-Coordinated Binder Networks for Durable and Kinetically Efficient Silicon Anodes.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

NHWD-870, a Potent BET Inhibitor, Ameliorated Endotoxemia-Induced Hepatic Inflammation via Suppression of BRD4-STAT1 Signaling and Macrophage M1 Polarization.

Journal of inflammation research·2026
This summary is machine-generated.

Tyrosine kinase inhibitors (TKIs) improve survival for recurrent hepatocellular carcinoma (HCC) after surgery. Machine learning models personalize TKI therapy decisions, improving outcomes for high-risk HCC patients.

Area of Science:

  • Oncology
  • Hepatology
  • Translational Medicine

Background:

  • Postoperative recurrence significantly impacts prognosis in hepatocellular carcinoma (HCC) patients following curative resection.
  • Current use of tyrosine kinase inhibitors (TKIs) for recurrent HCC shows interpatient variability, limiting universal benefit.
  • Lack of reliable tools hinders personalized treatment strategies for post-recurrence HCC management.

Purpose of the Study:

  • To evaluate the survival benefit of TKI therapy in patients with recurrent HCC after curative resection.
  • To develop and validate machine learning models for predicting survival in recurrent HCC.
  • To implement a counterfactual inference framework for individualizing post-recurrence treatment decisions.

Main Methods:

  • Retrospective analysis of 454 patients with recurrent HCC post-curative resection.
Keywords:
counterfactual reasoninghepatocellular carcinomamachine learningpostoperative recurrencetyrosine kinase inhibitor

More Related Videos

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Related Experiment Videos

Last Updated: Jun 23, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

  • Application of overlap weighting to balance TKI-treated and non-TKI-treated groups.
  • Development and validation of machine learning survival models (Surv-SVM, RSF) and counterfactual inference.

    • Main Results:

    • TKI therapy significantly improved recurrence-free survival (24 vs. 12 months) and overall survival (36 vs. 18 months).
    • Machine learning models demonstrated strong predictive performance (C-index up to 0.856) for survival in both TKI and non-TKI cohorts.
    • Counterfactual analysis identified potential treatment mismatches in 23.4% of patients, suggesting suboptimal therapy allocation.

    Conclusions:

    • TKI therapy offers a significant survival advantage for patients with recurrent HCC after curative resection.
    • A machine learning-based counterfactual framework can personalize treatment selection for recurrent HCC.
    • This approach supports precision management and improves outcomes in this high-risk patient population.